Khalid BAJOU
Khalid BAJOU
Verified email at
Cited by
Cited by
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
K Bajou, A NoŽl, RD Gerard, V Masson, N Brunner, C Holst-Hansen, ...
Nature medicine 4 (8), 923-928, 1998
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies
K Bajou, V Masson, RD Gerard, PM Schmitt, V Albert, M Praus, LR Lund, ...
The Journal of cell biology 152 (4), 777-784, 2001
Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation
EN Baramova, K Bajou, A Remacle, C L'hoir, HW Krell, UH Weidle, ...
FEBS letters 405 (2), 157-162, 1997
The pro‐or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent
L Devy, S Blacher, C Grignet-Debrus, K Bajou, V Masson, RD Gerard, ...
The FASEB Journal 16 (2), 147-154, 2002
The antitumoral effect of endostatin and angiostatin is associated with a down‐regulation of vascular endothelial growth factor expression in tumor cells
A Hajitou, C Grignet‐Debrus, L Devy, S Berndt, S Blacher, CF Deroanne, ...
The FASEB journal 16 (13), 1-23, 2002
Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes
V Masson, LR De La Ballina, C Munaut, B Wielockx, M Jost, C Maillard, ...
The FASEB Journal 19 (2), 1-17, 2005
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth
K Bajou, C Maillard, M Jost, RH Lijnen, A Gils, P Declerck, P Carmeliet, ...
Oncogene 23 (41), 6986-6990, 2004
Mouse aortic ring assay: a new approach of the molecular genetics of angiogenesis
V Masson, L Devy, C Grignet-Debrus, S Bernt, K Bajou, S Blacher, ...
Biological procedures online 4 (1), 24-31, 2002
Role of plasminogen activator-plasmin system in tumor angiogenesis
JM Rakic, C Maillard, M Jost, K Bajou, V Masson, L Devy, V Lambert, ...
Cellular and Molecular Life Sciences CMLS 60 (3), 463-473, 2003
Emerging roles for proteinases in cancer
A NoŽl, C Gilles, K Bajou, L Devy, F Kebers, JM Lewalle, E Maquoi, ...
Invasion and metastasis 17 (5), 221-39, 1997
Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis
K Bajou, H Peng, WE Laug, C Maillard, A Noel, JM Foidart, JA Martial, ...
Cancer cell 14 (4), 324-334, 2008
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization
V Lambert, C Munaut, A NoŽl, F Frankenne, K Bajou, R Gerard, ...
The FASEB Journal 15 (6), 1021-1027, 2001
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
K Bajou, S Herkenne, VL Thijssen, S D'amico, NQN Nguyen, A Bouchť, ...
Nature medicine 20 (7), 741-747, 2014
Alteration of Interendothelial Adherens Junctions Following Tumor Cell–Endothelial Cell Interactionin Vitro
JM Lewalle, K Bajou, J Desreux, M Mareel, E Dejana, A NoŽl, JM Foidart
Experimental cell research 237 (2), 347-356, 1997
Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization
JM Rakic, V Lambert, C Munaut, K Bajou, K Peyrollier, ...
Investigative ophthalmology & visual science 44 (4), 1732-1739, 2003
Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner
C Maillard, M Jost, MU RÝmer, N Brunner, X Houard, A Lejeune, ...
Neoplasia 7 (1), 57-66, 2005
Endothelial cell intracellular Ca concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration
JM Lewalle, D Cataldo, K Bajou, CA Lambert, JM Foidart
Clinical & experimental metastasis 16 (1), 21-29, 1998
Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA‐PAI‐1 and by enhancing their expression
K Bajou, JM Lewalle, CR Martinez, C Soria, H Lu, A NoŽl, JM Foidart
International journal of cancer 100 (5), 501-506, 2002
Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia. A possible etiology for venous disease.
C Michiels, T Arnould, D Janssens, K Bajou, I Geron, J Remacle
International Angiology: A Journal of the International Union of Angiology†…, 1996
DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase
M Amand, C Erpicum, K Bajou, F Cerignoli, S Blacher, M Martin, ...
Molecular cancer 13 (1), 1-18, 2014
The system can't perform the operation now. Try again later.
Articles 1–20